» Articles » PMID: 29332704

Cutaneous Squamous Cell Carcinoma: Incidence, Risk Factors, Diagnosis, and Staging

Overview
Specialty Dermatology
Date 2018 Jan 16
PMID 29332704
Citations 291
Authors
Affiliations
Soon will be listed here.
Abstract

Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous epithelium, represents 20% to 50% of skin cancers. Although the majority of cSCCs are successfully eradicated by surgical excision, a subset of cSCC possesses features associated with a higher likelihood of recurrence, metastasis, and death. The proper identification of these aggressive cSCCs can guide additional work-up and management. In the first article in this continuing medical education series, we discuss the incidence, recurrence rates, mortality rates, and risk factors associated with cSCC and review the staging systems used to stratify patients into high- and low-risk groups. The second article in this series reviews the treatment options for cSCC, with focused attention on the management of high-stage tumors.

Citing Articles

Human Papillomavirus-Related Cutaneous Squamous Cell Carcinoma.

Sandoval-Clavijo A, Marti-Marti I, Ferrandiz-Pulido C, Verdaguer-Faja J, Jaka A, Toll A Cancers (Basel). 2025; 17(5).

PMID: 40075744 PMC: 11898954. DOI: 10.3390/cancers17050897.


Effectiveness and Toxicity of Cemiplimab Therapy for Advanced Cutaneous Squamous Cell Skin Cancer in a Community Oncology Practice.

Fung T, Samlowski W, Meoz R Cancers (Basel). 2025; 17(5).

PMID: 40075670 PMC: 11899135. DOI: 10.3390/cancers17050823.


Three Synchronous Non-melanoma Skin Cancers of the Head and Neck: A Case Report and Literature Review.

Keshk E, Moussa A, Kashif A, Alsulaiman A, Alafghani S, Abdullah N Cureus. 2025; 17(1):e78020.

PMID: 40013203 PMC: 11859851. DOI: 10.7759/cureus.78020.


Immunological Landscape of Non-Melanoma Skin Neoplasms: Role of CTLA4+IFN-γ+ Lymphocytes in Tumor Microenvironment Suppression.

Karabatic Knezovic S, Knezovic D, Ban J, Matana A, Puizina Ivic N, Glavina Durdov M Medicina (Kaunas). 2025; 61(2).

PMID: 40005446 PMC: 11857809. DOI: 10.3390/medicina61020330.


Neoadjuvant Immunotherapy in Cutaneous Squamous Cell Carcinoma: Systematic Literature Review and State of the Art.

Spadafora M, Paganelli A, Raucci M, Kaleci S, Peris K, Guida S Cancers (Basel). 2025; 17(4).

PMID: 40002232 PMC: 11852655. DOI: 10.3390/cancers17040637.